Erk1R84H is an oncoprotein that causes hepatocellular carcinoma in mice and imposes a rigorous negative feedback loop

Nadine Soudah1, Alexey Baskin1, Merav Darash-Yahana1

  • 1Department of Biological Chemistry, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.

Oncogene
|May 20, 2025
PubMed

Insights

The engineered Erk1 protein can cause liver cancer in mice, indicating it may be the primary driver of this pathway

Area of Science:

  • Oncology
  • Molecular Biology
  • Signal Transduction

Background:

  • The receptor tyrosine kinase (RTK)-Ras-Raf-MEK-Erk pathway is frequently altered in various cancers.
  • The precise role and required activity level of Erk in mediating oncogenicity remain unclear.

Purpose of the Study:

  • To investigate if Erk is the sole mediator of the RTK-Ras-Raf-MEK-Erk pathway's oncogenic potential.
  • To determine the degree of Erk activity necessary for oncogenicity.

Main Methods:

  • Induced expression of an intrinsically active Erk1 variant (Erk1R84H) in mouse liver.
  • Analysis of Erk1R84H phosphorylation levels during hepatocellular carcinoma (HCC) development.
  • Examination of Erk1R84H-transformed NIH3T3 cells.

Main Results:

  • Induced Erk1R84H expression in mouse liver led to hepatocellular carcinoma (HCC).
  • Active phosphorylated Erk1R84H levels decreased significantly during HCC progression and were undetectable in mature tumors.
  • Phosphorylated Erk1R84H was also undetectable in Erk1R84H-transformed NIH3T3 cells.

Conclusions:

  • Erk1 can independently induce HCC, suggesting it's a major or sole oncogenic mediator in its pathway.
  • Tumor maintenance driven by Erk1R84H requires only minimal Erk activity.
  • The Erk1R84H mutation is likely a driver of malignancy in human cancers.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.3K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
76.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K